Most Recent

image: Remaking a Classic

Remaking a Classic

By Megan Scudellari | September 1, 2013

Companies are bursting at the seams with tools to engineer pharma’s next magic bullet: the new and improved antibody.


image: How Safe Is Your Medicine Cabinet?

How Safe Is Your Medicine Cabinet?

By Megan Scudellari | May 1, 2013

After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.

1 Comment

image: A Dime a Dozen

A Dime a Dozen

By Megan Scudellari | January 1, 2013

Affordable diagnostic tests tackle the world’s most pressing health problems.


image: Tumor Snipers

Tumor Snipers

By Megan Scudellari | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.


image: The Little Cell That Could

The Little Cell That Could

By Megan Scudellari | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Treating Fat with Fat

Treating Fat with Fat

By Edyta Zielinska | May 1, 2012

Is brown fat ready for therapeutic prime time?


image: Braving the IPO Drought

Braving the IPO Drought

By Megan Scudellari | March 1, 2012

Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.


image: New Tech Boosts Science

New Tech Boosts Science

By Tia Ghose | October 1, 2011

From iPhone apps to cloud computing, everyday digital technologies are helping advance drug discovery, conduct clinical trials, and improve medical care.


image: Make Mine Rare

Make Mine Rare

By Megan Scudellari | August 1, 2011

With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.


image: Take Two of These

Take Two of These

By Bob Grant | June 22, 2011

Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.


Popular Now

  1. Could Rapamycin Help Humans Live Longer?
  2. Renowned Physicist Stephen Hawking Dies
  3. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  4. University of Oregon Erecting a $1-Billion Science Center